Australia · Delayed Price · Currency is AUD TrivarX Statistics
Total Valuation
TrivarX has a market cap or net worth of AUD 17.31 million. The enterprise value is 14.99 million.
| Market Cap | 17.31M |
| Enterprise Value | 14.99M |
Important Dates
The last earnings date was Friday, August 28, 2026.
| Earnings Date | Aug 28, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TrivarX has 1.15 billion shares outstanding. The number of shares has decreased by -98.15% in one year.
| Current Share Class | 1.15B |
| Shares Outstanding | 1.15B |
| Shares Change (YoY) | -98.15% |
| Shares Change (QoQ) | -98.66% |
| Owned by Insiders (%) | 18.89% |
| Owned by Institutions (%) | 7.15% |
| Float | 901.38M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1,188.07 |
| PB Ratio | 1.08 |
| P/TBV Ratio | 5.07 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.26, with a Debt / Equity ratio of 0.01.
| Current Ratio | 5.26 |
| Quick Ratio | 5.16 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.09 |
| Interest Coverage | -673.21 |
Financial Efficiency
Return on equity (ROE) is -61.23% and return on invested capital (ROIC) is -36.34%.
| Return on Equity (ROE) | -61.23% |
| Return on Assets (ROA) | -35.01% |
| Return on Invested Capital (ROIC) | -36.34% |
| Return on Capital Employed (ROCE) | -52.35% |
| Weighted Average Cost of Capital (WACC) | 8.80% |
| Revenue Per Employee | 2,428 |
| Profits Per Employee | -1.46M |
| Employee Count | 6 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +40.00% in the last 52 weeks. The beta is 0.83, so TrivarX's price volatility has been lower than the market average.
| Beta (5Y) | 0.83 |
| 52-Week Price Change | +40.00% |
| 50-Day Moving Average | 0.02 |
| 200-Day Moving Average | 0.02 |
| Relative Strength Index (RSI) | 39.05 |
| Average Volume (20 Days) | 596,394 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TrivarX had revenue of AUD 14,566 and -8.76 million in losses. Loss per share was -0.96.
| Revenue | 14,566 |
| Gross Profit | 14,566 |
| Operating Income | -8.41M |
| Pretax Income | -8.76M |
| Net Income | -8.76M |
| EBITDA | -1.93M |
| EBIT | -8.41M |
| Loss Per Share | -0.96 |
Balance Sheet
The company has 2.44 million in cash and 128,136 in debt, with a net cash position of 2.32 million or 0.00 per share.
| Cash & Cash Equivalents | 2.44M |
| Total Debt | 128,136 |
| Net Cash | 2.32M |
| Net Cash Per Share | 0.00 |
| Equity (Book Value) | 15.97M |
| Book Value Per Share | 0.01 |
| Working Capital | 2.02M |
Cash Flow
| Operating Cash Flow | -1.51M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 6.47M |
| Net Borrowing | -47,964 |
| Free Cash Flow | -1.51M |
| FCF Per Share | -0.00 |
Margins
| Gross Margin | 100.00% |
| Operating Margin | -57,721.44% |
| Pretax Margin | -60,158.20% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TrivarX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 98.15% |
| Shareholder Yield | 98.15% |
| Earnings Yield | -50.64% |
| FCF Yield | -8.70% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on October 24, 2023. It was a reverse split with a ratio of 0.05.
| Last Split Date | Oct 24, 2023 |
| Split Type | Reverse |
| Split Ratio | 0.05 |
Scores
TrivarX has an Altman Z-Score of 8.08 and a Piotroski F-Score of 2.
| Altman Z-Score | 8.08 |
| Piotroski F-Score | 2 |